Tangji EU Gastric Bypass Stent Study for Obesity

NCT05249608 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Obesity

Interventions

DEVICE: A prospective, open-label, multicenter, single-arm clinical study to evaluate the safety and performance of the Gastric Bypass Stent System as a weight loss treatment for obesity

Sponsor

Hangzhou Tangji Medical Technology Co., Ltd.